Papillary Thyroid Cancer
54
13
18
23
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.4%
4 terminated out of 54 trials
85.2%
-1.4% vs benchmark
4%
2 trials in Phase 3/4
30%
7 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 23 completed trials
Clinical Trials (54)
Incidental Thyroid Cancer in Cases With Inflammatory Thyroid Lesion
Frozen Section-Guided Selective Ipsilateral Central Neck Dissection in Bethesda V-VI Thyroid Nodules
Studies on Tumors of the Thyroid
Clinical Utility of Preoperative Thyroid GuidePx® Testing
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated
Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer
Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation